Skip to content

Optimization of the Conditioned Pain Modulation Protocol using the Q-sense

Optimization of the Conditioned Pain Modulation Protocol using the Q-sense - CPMQ study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42364
Enrollment
30
Registered
2015-08-25
Start date
2015-10-05
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endogene pijnstilling healthy volunteers pain measurements

Interventions

Pain measurements

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers, aged 18 to 35 years, right-handed.

Exclusion criteria

Exclusion criteria: - Unable to understand study information or give oral and written informed consent; - Obesity (BMI > 30 kg/m2); - History of chronic alcohol or illicit drug use; - History of illness, condition or medication use that, in the opinion of the investigator, might interfere with optimal participation, or could confound the results of the study; - Pregnancy / lactation

Design outcomes

Primary

MeasureTime frame
The aim of this study is to assess the usefulness of the Q-sense CPM device for CPM studies. The end-point is defined as: reproducible and significant pain relief of the test stimulus when combined with the appropriate conditioning stimulus.

Secondary

MeasureTime frame
Furthermore, we will evaluate whether the anatomic site used will impact the measured CPM effect.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)